[1]Aaron AD. The management of cancer metastatic to bone[J]. JAMA,1994, 272: 1206-1209.
[2]李锦新, 张启周, 栗国梁. 125I放射性粒子植入治疗骨转移瘤的临床观察[J]. 影像诊断与介入放射学, 2011, 20: 55-57.
[3]Ling CC, Yorke ED, Spiro IJ, et al. Physical dosimetry of 125I seeds of a new design for interstitial implant[J]. Int J Radiat Oncol Biol Phys, 1983, 9: 1747-1752.
[4]Hallab NJ, Bundy KJ, O’connor K, et al. Evaluation of metallic and polymeric biomaterial surface energy and surface roughness characteristics for directed cell adhesion[J]. Tissue Eng, 2001, 7: 55-71.
[5]Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment[J]. Cancer, 1981, 47: 207-214.
[6]Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006[J]. CA Cancer J Clin, 2006, 56: 106-130.
[7]Quraishi NA, Giannoulis KE, Edwards KL, et al. Management of metastatic sacral tumours[J]. Eur Spine J, 2012, 21: 1984-1993.
[8]Settle WJ, Ebraheim NA, Coombs R, et al. CT-guided biopsy of metastatic sacral tumors[J]. Orthopedics, 1990, 13: 753-758.
[9]Luger NM, Honore P, Sabino MA, et al. Osteoprotegerin diminishes advanced bone cancer pain[J]. Cancer Res, 2001, 61: 4038-4047.
[10]孙燕, 管忠震, 廖美琳, 等. 肺癌骨转移诊疗专家共识(2014版)[J]. 中国肺癌杂志, 2014, 17: 57-72.
[11]田庆华, 吴春根, 顾一峰, 等. 经皮骨成形术治疗椎外转移性骨肿瘤的应用[J]. 介入放射学杂志, 2012, 21: 645-650.
[12]肖全平, 吴春根, 王涛, 等. 125I粒子植入联合经皮椎体成形术治疗累及硬膜囊脊椎转移瘤[J]. 介入放射学杂志, 2014, 23: 1052-1055.
[13]文世民, 胡兴胜, 于 英. 心理干预对癌痛患者止痛效果的影响[J]. 中国实用神经疾病杂志, 2014, 17: 126-127.
[14]唐小玲, 毛绍蓉, 蒋 欧, 等. CT导引125I粒子植入治疗肝癌25例临床分析[J]. 现代临床医学, 2010, 36: 277-278.
[15]殷蔚伯, 余子豪, 徐国镇, 等. 肿瘤放射治疗学[M]. 北京: 中国协和医科大学出版社, 2008: 1-17.
[16]贺克武, 高 斌. CT 导引下125I粒子组织间植入治疗肿瘤的应用[J]. 解放军医学杂志, 2007, 32: 411-412.
[17]陆晓涛, 罗开元, 侯开宇, 等. 125Ⅰ粒子永久组织间植入治疗脊柱转移性骨肿瘤的初探[J]. 心血管病防治知识·学术版, 2013, 5: 86-87.
[18]Jin YX, Liu XH. Application of 125I interstitial implantation in cancerous pain[J]. Int J Oncol, 2008, 35: 426-428.
[19]王纯, 王修, 陈健. 125I粒子植入合并骨水泥治疗骨转移癌疗效分析[J]. 中外医疗, 2014, 33: 88-89.
[20]江旭, 颜红菊, 陈文会, 等. B型超声引导125I 粒子植入治疗溶骨性骨转移瘤18例[J]. 介入放射学杂志, 2015, 24: 346-349.